Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

OMIC - Singular Genomics Systems Inc


IEX Last Trade
7
-0.090   -1.286%

Share volume: 1,021
Last Updated: Fri 30 Aug 2024 09:00:28 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$7.09
-0.09
-1.27%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
20%
Profitability 0%
Dept financing 9%
Liquidity 75%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
12.11%
1 Month
-12.20%
3 Months
-34.91%
6 Months
-59.62%
1 Year
-49.58%
2 Year
-91.29%
Key data
Stock price
$7.00
P/E Ratio 
-0.19
DAY RANGE
N/A - $7.20
EPS 
-$37.37
52 WEEK RANGE
$5.77 - $19.80
52 WEEK CHANGE
-$0.50
MARKET CAP 
17.739 M
YIELD 
N/A
SHARES OUTSTANDING 
2.496 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/12/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,556
AVERAGE 30 VOLUME 
$6,846
Company detail
CEO:
Region: US
Website: singulargenomics.com
Employees: 250
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

singular genomics is a venture capital backed biotech company in la jolla, california. we foster a dynamic, fast paced, result oriented environment where we offer employees the opportunity to make a significant impact in a rapidly expanding company. singular genomics is inventing at the forefront of genomics, one of the world’s fastest growing industries. we are located in the center of the biotech hub on the torrey mesa close to the pacific ocean and next door to prestigious institutions like the salk institute, scripps, sanford burnham, and ucsd. we offer free gym membership, 401k plan, competitive health benefits, flexible vacation, and equity incentives, so you can grow as the company grows. we are working to accelerate genomics for the advancement of science and medicine and are passionate about the potential of genomics for improving human health.

Recent news